| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 08/14/2008 | US20080196114 Recombinant rodent comprising modified repulsive guidance molecule gene for use in identifying modulator for treatment and prevention of vision defects |
| 08/14/2008 | US20080196112 Using vector transformation to generate cells for use as bioreactor to prepare/express humanized antibodies |
| 08/14/2008 | US20080196111 Expression Vectors and Methods for Obtaining Nk Cell Specific Expression |
| 08/14/2008 | US20080196110 Recombinant non-human mammal expressing mesenchymal-epithelial transition factor (MET) receptor for use as tool in identifying modulators for treatment of cell proliferative disorders |
| 08/14/2008 | US20080194797 Leucine-based motif and clostridial neurotoxins |
| 08/14/2008 | US20080194701 DNA molecules isolated from Streptococcus agalactiae, comprising genes responsible for gamma -glutamyl-L-cysteinylglycine synthesis; drug design; treatment of infections caused by streptococcus agalactiae |
| 08/14/2008 | US20080194540 Desipramine, imipramine, trimipramine, amitriptyline, nortriptyline, doxepin, amoxapine, or maprotyline and chloroquine, promazine, quinine, biquinoline, phenothiazine or chlorpromazine; transfection or gene therapy |
| 08/14/2008 | US20080194521 Diacylhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complex |
| 08/14/2008 | US20080194515 Extracting DNA from a blood or buccal cell sample, PCR, resolution, and identification of differences in sequences between the extracted DNA and PCR primers; drug screening |
| 08/14/2008 | US20080194514 Methods and Compositions for Inhibiting the Function of Polynucleotide Sequences |
| 08/14/2008 | US20080194513 RNAi-MEDIATED INHIBITION OF AQUAPORIN 4 FOR TREATMENT OF OCULAR NEOVASCULARIZATION |
| 08/14/2008 | US20080194512 Compositions and methods for inhibiting viral replication |
| 08/14/2008 | US20080194511 Encoding somatoliberin (GHRH) and comprising a eukaryotic promoter; a 5' untranslated region, a codon-optimized-eukaryotic therapeutic gene sequence, and a polyadenylation signal; plasmid mediated gene supplementation |
| 08/14/2008 | US20080194504 Rna-Mediated Interference to Control Disease in Terrestrial and Aquaculture Animals |
| 08/14/2008 | US20080194503 Antisense Modulation of P38 Mitogen Activated Protein Kinase Expression |
| 08/14/2008 | US20080194481 Albumin Fusion Proteins |
| 08/14/2008 | US20080194480 Polypeptide for reducing the growth rate of cancer cells; polypeptide of given sequence that is down-regulated in cancer |
| 08/14/2008 | US20080194477 Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules |
| 08/14/2008 | US20080194475 mutant erythropoietin (EPO) having improved stability as measured by a ratio of the ability of an EPO variant to bind the EPO receptor in the presence of dithiothreitol (DTT), in a radioimmunoassay, versuses the ability in the absence of DTT in the same radioimmunoassay |
| 08/14/2008 | US20080194472 Use of Fgf-18 Protein, Target Proteins and Their Respective Encoding Nucleotide Sequences to Induce Cartilage Formation |
| 08/14/2008 | US20080194032 Methods and compositions for curing persistent I-complex super-family plasmids |
| 08/14/2008 | US20080194031 Using nanodiamond particles to transfer preferential nucleotide sequences into cells; gene expression analysis; gene therapy |
| 08/14/2008 | US20080194030 Generating L-methionine producing escherichia strain via multiple vector transformation |
| 08/14/2008 | US20080194029 Method for Increasing the Ratio of Homologous to Non-Homologous Recombination |
| 08/14/2008 | US20080194028 Highly Potent Hsirna Mixtures and Method for Gene Splicing |
| 08/14/2008 | US20080194027 Compositions, methods and kits based on small nuclear RNAs |
| 08/14/2008 | US20080194020 Methods For Producing Dendritic Cells That Have Acquired Ctl-Inducing Ability |
| 08/14/2008 | US20080194005 Chrysosporium mutants for use as bioreactor in production/fermentation of heterologous polypeptides |
| 08/14/2008 | US20080194004 Point mutations; antibodies; fusion proteins |
| 08/14/2008 | US20080194002 Buffered polyhydroxy hydrocarbon solution comprising adenoviral vector; enhanced stability; gene therapy |
| 08/14/2008 | US20080193999 Heat resistant hydrolase for enhancing wash performance of detergents |
| 08/14/2008 | US20080193998 Modified hydrolase for use in production of riboflavin, riboflavin precursors, riboflavin monophosphate (FMN) and riboflavin 5'adenosine diphosphate (FAD) |
| 08/14/2008 | US20080193983 Quasirandom Structure and Function Guided Synthesis Methods |
| 08/14/2008 | US20080193980 Fusion protein of Fc-binding domain and calcium-binding photoprotein, gene encoding the same and use thereof |
| 08/14/2008 | US20080193979 Using constitutive hypermutation by vairant DNA repair protein as tool in directed protein evolution |
| 08/14/2008 | US20080193977 Gene Expression Technique |
| 08/14/2008 | US20080193976 Pseudomonas Exotoxin A Cd4+T-Cell Epitopes |
| 08/14/2008 | US20080193975 Mutated d-aminotransferase and method for producing optically active glutamic acid derivatives using the same |
| 08/14/2008 | US20080193974 Expression vector comprising nucleotoide sequences coding signal sequences which direct proteins to periplasmic compartment; improving exogenous expression of heterologous polypeptides |
| 08/14/2008 | US20080193972 Gene Rcs 25 |
| 08/14/2008 | US20080193970 Using photosynthetic bacteria mutants as bioreactor for production of beta -carotene, canthaxanthin or astaxanthin |
| 08/14/2008 | US20080193969 Using microorganismal bioreactor to ferment oxygen-binding protein |
| 08/14/2008 | US20080193944 Expression vector comprising nucleotide sequences coding cardiac-related ankyrin-repeat protein kinase (CARK) for diagnosis, treatment and prevention of cardiovascular disorders |
| 08/14/2008 | US20080193939 Corneodesmosin based test and model for inflammatory disease |
| 08/14/2008 | US20080193933 Method of generating transgenic organisms using transposons |
| 08/14/2008 | US20080193925 Thermostable Y-Family Polymerases and Chimeras |
| 08/14/2008 | US20080193924 Reacting astemizole with potassium channel moderators; complexing; calibration; kits |
| 08/14/2008 | US20080193918 Compositions and methods for monosynaptic transport |
| 08/14/2008 | US20080193864 Masks for performing in-situ synthesis on probes, comprising light-transmitting regions and light-blocking regions, and a proportion of the light-transmitting regions is equal to or greater than 5% of a total proportion of the light-transmitting and light-blocking regions in each mask |
| 08/14/2008 | US20080193593 Barley Lipoxygenase 1 Gene, Method of Selecting Barley Variety, Material of Malt Alcoholic Drinks and Process For Producing Malt Alcoholic Drink |
| 08/14/2008 | US20080193510 Nucleic acids, peptides, and antibodies for use in diagnosis and therapy; macular degeneration; cancers of the colon, breasts, prostate, liver, pancreas, and mouth; receptor binding assays of the peptide to neovasulatures |
| 08/14/2008 | US20080193488 Variant Polypeptide and Screening Assay |
| 08/14/2008 | US20080193486 Live, Oral Vaccine for Protection Against Shigella Dysenteriae Serotype 1 |
| 08/14/2008 | US20080193484 Novel Methods for Producing Adenoviral Vector Preparations with Reduced Replication-Competent Adenovirus Contamination and Novel Adenoviral Vectors and Preparations |
| 08/14/2008 | US20080193471 Novel h5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use |
| 08/14/2008 | US20080193467 Dendritic cell potentiation |
| 08/14/2008 | US20080193465 Human Monoclonal Antibodies that Specifically Bind Igf-II |
| 08/14/2008 | US20080193458 125p5c8: tissue specific protein highly expressed in various cancers |
| 08/14/2008 | US20080193457 Major histocompatibility complex peptide for use in treatment and prevention of rheumatoid arthritis (RA) |
| 08/14/2008 | US20080193454 Identification of Surface-Associated Antigens for Tumor Diagnosis and Therapy |
| 08/14/2008 | US20080193449 Antibodies specific for DKK-1 |
| 08/14/2008 | US20080193447 Gamma-1 and gamma-3 anti-human cd23 monoclonal antibodies and use thereof as therapeutics |
| 08/14/2008 | US20080193439 Non-sensitive antigenic peptide derived from fc portion of the epsilon heavy chain of immunoglobulin-E for use in treatment and prevention of allergic disorders |
| 08/14/2008 | US20080193437 Two oligonucleotides each containing 2'-deoxy-7-deazaguanosine and linked by a non-nucleotide linker and where the sequences are at least partially self-complementary; anticarcinogenic agents; antiinflammatory agents; autoimmune diseases; antiallergens asthma; disease; gene therapy; vertabrates |
| 08/14/2008 | US20080193426 Increasing homing of CD34 by administering chemokines, fusion protein; irradiation, cyclophosphamide or 5-fluorouracil; interleukins; Gaucher disease |
| 08/14/2008 | US20080193417 DNA encoding insecticidal CRY9Fa bacillus thuringiensis proteins and recombinant hosts expressing same |
| 08/14/2008 | US20080193416 Vectors used to generate modified artificial chromosomes; cleavage sites that flank origin of replication, antibiotic resistance gene and sequence that encodes fluorescent protein |
| 08/14/2008 | US20080193375 Lung cancer-targeted peptides and applications thereof |
| 08/14/2008 | DE102007006008A1 Method for isolating plasmid DNA from bacterial lysate, involves resuspending bacterial cells in standard buffer, and bacterial cells are lysed with standard buffer e.g. sodium dodecyl sulphate or sodium hydroxide |
| 08/14/2008 | DE102005047736B4 Verfahren und System zur Isolierung von Nukleinsäuren aus beliebigen komplexen Ausgangsmaterialien Method and system for isolating nucleic acids from any complex starting materials |
| 08/14/2008 | CA2856143A1 Droplet actuator devices and methods employing magnetic beads |
| 08/14/2008 | CA2678261A1 Biofuel production by recombinant microorganisms |
| 08/14/2008 | CA2678257A1 Water deficit-inducible promoters |
| 08/14/2008 | CA2677996A1 Gaba neuron progenitor cell marker 65b13 |
| 08/14/2008 | CA2677659A1 Attenuated minus-stranded rna virus |
| 08/14/2008 | CA2677630A1 Compositions and methods using rna interference of cdpk-like for control of nematodes |
| 08/14/2008 | CA2677475A1 Expression of polypeptides from the nuclear genome of ostreococcus sp |
| 08/14/2008 | CA2677455A1 Recombinant antigens of human cytomegalovirus (hcmv) |
| 08/14/2008 | CA2677342A1 Variant buttiauxella sp. phytases having altered properties |
| 08/14/2008 | CA2677154A1 Genetically modified yeasts for the production of homogeneous glycoproteins |
| 08/14/2008 | CA2677119A1 Mutations in human ubiad1 |
| 08/14/2008 | CA2676682A1 Compositions and methods using rna interference targeting mthfr -like genes for control of nematodes |
| 08/14/2008 | CA2676295A1 Compositions and methods of using rna interference of sca1-like genes for control of nematodes |
| 08/14/2008 | CA2676293A1 Polynucleotides encoding truncated sucrose isomerase polypeptides for control of parasitic nematodes |
| 08/14/2008 | CA2676036A1 Hepcidin, hepcidin antagonists and methods of use |
| 08/14/2008 | CA2675698A1 Pearli1-like pathogen control genes and methods of use in plants |
| 08/14/2008 | CA2675255A1 Use of trehalase genes to confer nematode resistance to plants |
| 08/14/2008 | CA2674564A1 Compositions and methods using rna interference of cad-like genes for control of nematodes |
| 08/14/2008 | CA2674562A1 Compositions and methods using rna interference of opr3-like gene for control of nematodes |
| 08/14/2008 | CA2674499A1 Use of alanine racemase genes to confer nematode resistance to plants |
| 08/14/2008 | CA2674497A1 Nematode inducible promoters and methods of use |
| 08/14/2008 | CA2674495A1 Nematode inducible plant mtn3-like gene promoters and regulatory elements |
| 08/14/2008 | CA2674494A1 Compositions and methods using rna interference for control of nematodes |
| 08/14/2008 | CA2671825A1 Highly transcriptionally active cell line for the producion of proteins, notably for therapeutic applications |
| 08/14/2008 | CA2663027A1 Tcl1 expression in chronic lymphocytic leukemia (cll) regulated by mir-29 and mir-181 |
| 08/13/2008 | EP1956094A1 Promoters for expression in modified vaccinia virus ankara |
| 08/13/2008 | EP1956093A1 von Willebrand Factor (vWF)-cleaving protease |
| 08/13/2008 | EP1956092A1 Mouse with a silenced lambda light chain locus |
| 08/13/2008 | EP1956091A2 Alzheimer's disease animal model, method for obtaining same and uses thereof |
| 08/13/2008 | EP1956090A1 Novel protein and dna encoding the protein |